Dr. Deb Kimless has been in the medical cannabis field since 2013 where her diverse involvement spans many areas including cannabis cultivation, processing, formulation, testing, patient care, and conducting research. She consults within the industry as an advisor for companies who are interested in novel formulations specific to medical conditions, develops protocols, obtains IRB approval, conducts clinical trials, and helps to publish the results.

At CannMed 24, Deb presented a poster that shared data from an open-label clinical trial investigating using a cannabinoid-enhanced topical cream for alleviating Restless Leg Syndrome. RLS is condition that affects up to 10% of the US population, including Deb. She found relief using a CBDA-based topical cream and is working with the product manufacturer to conduct clinical trials that demonstrate its effectiveness. 

During our conversation, we discuss: 

• The symptoms of RLS and possible causes 


• Deb’s own struggles with RLS 


• Why many conventional and pharmaceutical treatments of RLS fall short 


• Why CBDA appears to be effective at alleviating RLS symptoms 


• Why a transdermal approach is better than ingesting or inhaling cannabinoids 


• Results from the open label clinical trial including some remarkable success stories 

Thanks to This Episode’s Sponsor: Trusted Canna Nurse

Trusted Canna Nurse was founded by Megan Mbengue and Ariane Williams, two nurses who are dedicated to bridging the gap between traditional medicine and the world of cannabis and psychedelics. They specialize in creating evidence-based treatment plans for all ages that address chronic illnesses, treatment-resistant conditions, mental health, autism, and more. 

Learn more at trustedcannanurse.com 

Additional Resources

• chylorelief.com – USE CODE “CANNMED20” for 20% OFF!


• Email Deb – dkimless@gmail.com


• Review the Podcast


• CannMed Archive